Eli Lilly | LLY - Current Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Eli Lilly

Eli Lilly reported $20.81B in Current Assets for its fiscal quarter ending in March of 2023.


Current Assets Change
Abbott ABT:US USD 24.38B 847M
ALKERMES ALKS:US USD 1.11B 20.25M
Amgen AMGN:US USD 44.7B 22.52B
AstraZeneca AZN:LN USD 22.27B 327M
Baxter International BAX:US USD 8.1B 88M
Biogen BIIB:US USD 9.76B 28.7M
Catalent CTLT:US USD 2.92B 220M
Coherus Biosciences CHRS:US USD 402.43M 21.19M
Drreddys Laboratories RDY:US INR 206.94B 12.45B
Eli Lilly LLY:US USD 20.81B 2.78B
Endo International ENDP:US USD 1.93B 145.01M
Gilead Sciences GILD:US USD 14.37B 855M
GlaxoSmithKline GSK:LN GBP 19.72B 1.05B
Glaxosmithkline GSK:US GBP 19.72B 1.05B
Horizon Pharma HZNP:US USD 3.6B 50M
Intercept Pharmaceuticals ICPT:US USD 490.46M 49.67M
J&J JNJ:US USD 64.39B 9.09B
Neurocrine Biosciences NBIX:US USD 1.43B 20.7M
Novartis NOVN:VX USD 32.11B 4.8B
Novartis NVS:US USD 32.11B 4.8B
Perrigo PRGO:US USD 2.74B 20.8M
Phibro Animal Health PAHC:US USD 585.48M 3.79M
Prestige Brands PBH:US USD 391.74M 17.1M
Regeneron Pharmaceuticals REGN:US USD 16.91B 1.03B
Revance Therapeutics RVNC:US USD 323.02M 51.7M
Roche Holding ROG:VX CHF 33.82B 3.5B
United Therapeutics UTHR:US USD 3.19B 187.3M
Zoetis ZTS:US USD 6.27B 1.24B